In ₹ Crore except Per Share Latest Annual | NATHBIOGEN FY26 | SARVESHWAR FY26 | INDOUS FY26 | SUKHJITS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 7.27× | 13.76× | 12.28× | 28.32× | 13.76× -47% | |
| P/B | ◆ 0.43× | 1.03× | 1.74× | 0.88× | 1.03× -59% | |
| EV/EBITDA | ◆ 6.72× | 11.15× | 11.29× | 9.14× | 11.15× -40% | |
| Market Cap | ₹290 Cr | ₹491 Cr | ₹161 Cr | ₹500 Cr | ₹491 Cr -41% | |
| Growth | ||||||
| Revenue CAGR 3Y | 13.88% | ◆ 24.98% | — | -0.33% | 12.33% +13% | |
| Net Income CAGR 3Y | 5.93% | ◆ 59.78% | — | -24.72% | 17.53% -66% | |
| Revenue YoY (latest Q) | 15.76% | ◆ 18.81% | 7.21% | 7.18% | 7.21% +119% | |
| Net Income YoY (latest Q) | -13.46% | 17.04% | -35.41% | ◆ 142.51% | 17.04% -179% | |
| Profitability | ||||||
| EBITDA Margin | 11.78% | 4.91% | ◆ 15.40% | 5.77% | 5.77% +104% | |
| Net Income Margin | 9.35% | 2.36% | ◆ 11.88% | 1.89% | 2.36% +296% | |
| Return on Common Equity | 6.12% | 6.66% | ◆ 14.18% | 4.76% | 6.66% -8% | |
| Return on Capital Employed | 6.90% | 13.34% | ◆ 17.22% | 6.37% | 13.34% -48% | |
| Return on Assets | 3.79% | 2.92% | ◆ 9.86% | 2.48% | 2.92% +30% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.20× | 0.52× | 0.40× | 0.58× | 0.52× -62% | |
| Interest Coverage | 3.03× | 2.44× | ◆ 7.18× | 1.54× | 2.44× +24% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹445 Cr | ₹1,346 Cr | ₹110 Cr | ₹1,432 Cr | ₹1,346 Cr -67% | |
| Net Income | ₹41.6 Cr | ₹31.8 Cr | ₹13.1 Cr | ₹27 Cr | ₹27 Cr +54% | |
| Total Assets | ₹1,097 Cr | ₹1,089 Cr | ₹133 Cr | ₹1,089 Cr | ₹1,089 Cr +1% | |
| EPS | ₹20.98 | ₹0.29 | ₹6.54 | ₹5.65 | ₹5.65 +271% | |
| Book Value per Share | ₹358.06 | ₹3.88 | ₹46.15 | ₹181.62 | ₹46.15 +676% | |